SOVIHEP TABLET 28'S

No, SOVIHEP TABLET 28'S is not recommended as a monotherapy for hepatitis C. It is typically used in combination with other antiviral medications. The specific combination therapy will depend on factors such as the HCV genotype, previous treatment history, and the presence of liver cirrhosis.

SOVIHEP TABLET 28'S primarily treats individuals already infected with hepatitis C. While it can cure the infection and reduce the viral load, it does not provide direct protection against acquiring hepatitis C or prevent transmission to others. Prevention of hepatitis C transmission involves practicing safe behaviors such as using barrier methods during sexual activity, avoiding sharing needles or other drug paraphernalia, and taking precautions to prevent blood-to-blood contact.

Yes, SOVIHEP TABLET 28'S can be used in patients with liver cirrhosis. It has shown efficacy and safety in patients with compensated and decompensated liver cirrhosis. However, careful monitoring and individualized treatment plans may be required for patients with advanced liver disease.

Weight gain is not a commonly reported side effect of SOVIHEP TABLET 28'S. However, individual responses to medications can vary, and some patients may experience changes in weight during or after treatment.

Yes, SOVIHEP TABLET 28'S can be used in elderly patients. Age alone is not a contraindication for its use. However, elderly patients may have a higher likelihood of comorbidities and may be taking multiple medications, which can increase the risk of drug interactions.

Yes, SOVIHEP TABLET 28'S can be used in patients who are co-infected with both hepatitis C virus (HCV) and HIV. However, the choice may depend on the specific antiretroviral therapy used to treat HIV. Some antiretroviral medications can interact with it, potentially affecting the levels of both drugs in the body. It is crucial to work closely with healthcare providers to cure HCV and HIV co-infection to ensure optimal treatment outcomes.

Yes, SOVIHEP TABLET 28'S can be used in patients who are co-infected with both hepatitis C virus (HCV) and HIV. However, the choice may depend on the specific antiretroviral therapy used to treat HIV. Some antiretroviral medications can interact with it, potentially affecting the levels of both drugs in the body. It is crucial to work closely with healthcare providers to cure HCV and HIV co-infection to ensure optimal treatment outcomes.

Common side effects may include fatigue, headache, nausea, insomnia, diarrhea, itching, decreased appetite, and rash or skin reactions. Serious side effects are rare, including hepatitis B reactivation in co-infected individuals, serious bradycardia when combined with Amiodarone, and allergic reactions.

Yes, SOVIHEP TABLET 28'S can interact with certain medications. It's crucial to inform your healthcare provider about all drugs you are taking, especially Amiodarone, as combining it with SOVIHEP TABLET 28'S can cause serious bradycardia.

Before starting treatment, inform your healthcare provider if you have a history of hepatitis B; your liver function and HBV DNA levels will be closely monitored. Be aware of the risk of serious slow heart rate when combined with Amiodarone. Report any signs of allergic reactions immediately. Pregnant and breastfeeding individuals should discuss risks and benefits. Adhere to the prescribed regimen and attend regular check-ups.

SOFOSBUVIR is the active molecule/combination used to make SOVIHEP TABLET 28'S.

SOVIHEP TABLET 28'S is prescribed for treating Hepatitis.

Yes, SOVIHEP TABLET 28'S is used to treat Hepatitis.